Corcept Therapeutics (CORT) Short-term Investments (2017 - 2026)

Corcept Therapeutics (CORT) has 10 years of Short-term Investments data on file, last reported at $229.4 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 1.5% year-over-year to $229.4 million; the trailing twelve-month figure through Mar 2026 stood at $229.4 million (down 1.5% YoY), and the FY2025 full-year result was $251.7 million, down 1.57% from the prior year.
• Short-term Investments fell to $229.4 million in Q1 2026, from $251.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $365.3 million in Q4 2022 to a low of $165.1 million in Q1 2023.
• A 5-year average of $265.7 million and a median of $251.7 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments soared 150.38% in 2022 and sank 42.98% in 2023, its largest moves.
• Tracing CORT's Short-term Investments over 5 years: stood at $365.3 million in 2022, then plunged by 36.31% to $232.7 million in 2023, then climbed by 9.88% to $255.7 million in 2024, then dropped by 1.57% to $251.7 million in 2025, then decreased by 8.83% to $229.4 million in 2026.
• Business Quant data shows CORT's Short-term Investments at $229.4 million in Q1 2026, $251.7 million in Q4 2025, and $296.5 million in Q3 2025.